Over the last decade, the number of clinical trials involving recombinant adeno-associated viral (AAV) vectors has dramatically increased, the diversity of serotypes has expanded, and the demand for highlypurified material manufactured to cGMP standards has rocketed. For contract development and manufacturing organizations (CDMOs) like Yposkesi, the key manufacturing challenges are centered around flexibility, robustness, and productivity, especially with regard to purification. The availability of universal tools to address any serotype with minimal process adjustments is therefore critical. Yposkesi conducted aseries of experiments to evaluate the POROS™ CaptureSelect™ AAVX resin, a pan-affinity tool for universal capture of AAV vectors.
提供商 |
賽默飛世爾科技（中國）有限公司 | 下載次數(shù) |
0次 |
資料大小 |
447.1KB | 資料類型 |
PDF 文件 |
資料圖片 |
-- | 瀏覽次數(shù) |
94次 |
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)
3
立即詢價(jià)
您提交后，專屬客服將第一時(shí)間為您服務(wù)